+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Pentoxifylline Plus Prednisolone versus Pentoxifylline Only for Severe Alcoholic Hepatitis: A Randomized Controlled Clinical Trial



Pentoxifylline Plus Prednisolone versus Pentoxifylline Only for Severe Alcoholic Hepatitis: A Randomized Controlled Clinical Trial



Annals of Medical and Health Sciences Research 4(5): 810-816



Prednisolone and pentoxifylline (PTX) have been shown to be individually useful in severe alcoholic hepatitis with Maddrey discriminant function (MDF) score ≥32. Previous report suggests that PTX is probably superior to prednisolone alone. However the efficacy of PTX and prednisolone combination over PTX alone in the management of acute alcoholic hepatitis (MDF score ≥32) is yet unrevealed. The present study was initiated to find out the efficacy of combined pentoxifylline and prednisolone versus PTX alone in acute alcoholic hepatitis in respect of short and intermediate term outcomes. A total of 124 patients with severe alcoholic hepatitis (MDF score ≥ 32) initially were evaluated. 62 patients who fulfilled the inclusion and exclusion criteria were randomized and divided into 2 groups. Group 1 received PTX only, whereas Group 2 received PTX plus Prednisolone. The total duration of follow-up was 12 months. Student's t-test, Chi-square test, the Kaplan-Meier methods were used for statistical analysis. A total of 60 patients, 30 in each group were available for final analysis. In Group-1, 6 patients expired at the end of 1 year (5 within 3 months and another after 3 months). In Group 2, 10 patients expired at the end of 1 year (9 within 3 months and another after 3 months). Though survival probability is higher among Group 1 patients but the difference is not statistically significant. The combination of PTX plus Prednisolone yields no additional benefit in terms of mortality and morbidity from that of PTX monotherapy.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 054913077

Download citation: RISBibTeXText

PMID: 25328799


Related references

Pentoxifylline versus prednisolone for severe alcoholic hepatitis: a randomized controlled trial. World Journal of Gastroenterology 15(13): 1613-1619, 2009

Prednisolone with vs without pentoxifylline and survival of patients with severe alcoholic hepatitis: a randomized clinical trial. JAMA 310(10): 1033-1041, 2013

Corticosteroids Versus Pentoxifylline for Severe Alcoholic Hepatitis: A Sequential Analysis of Randomized Controlled Trials. Journal of Clinical Gastroenterology 50(10): 871-881, 2016

Pentoxifylline against prednisolone in severe acute alcoholic hepatitis: a Korean trial. La Revue du Praticien 64(9): 1206, 2015

Pentoxifylline Does Not Improve Short-Term Survival In Severe Alcoholic Hepatitis In Combination With Corticosteroids: Results Of A Randomized Controlled Trial. Journal of Hepatology 56: S533-S534, 2012

Pentoxifylline and prednisolone in severe alcoholic hepatitis. Annals of Hepatology 8(4): 402-404, 2009

Prednisolone vs. pentoxifylline for severe alcoholic hepatitis. Journal of Hepatology 61(4): 723-724, 2015

Metformin plus pentoxifylline versus prescriptive diet in non-alcoholic steatohepatitis (NASH): a randomized controlled pilot trial. Gastroenterologie Clinique et Biologique 33(10-11): 984-986, 2010

Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: A double-blind, placebo-controlled trial. Gastroenterology 119(6): 1637-1648, 2000

Pentoxifylline in severe alcoholic hepatitis: a prospective, randomised trial. Journal of the Association of Physicians of India 60: 20-22, 2012

PWE-113 The liver biopsy in alcoholic hepatitis: data from the steroids or pentoxifylline in alcoholic hepatitis (stopah) clinical trial. Gut 64(Suppl 1): A262.1-A262, 2015

Pentoxifylline for the treatment of non-alcoholic steatohepatitis: a randomized controlled trial. Annals of Hepatology 10(3): 277-286, 2011

Prednisolone or Pentoxifylline for Alcoholic Hepatitis. New England Journal of Medicine 373(3): 281-281, 2015

Prednisolone or Pentoxifylline for Alcoholic Hepatitis. New England Journal of Medicine 373(3): 281-282, 2015

The clinical effectiveness and cost-effectiveness of STeroids Or Pentoxifylline for Alcoholic Hepatitis (STOPAH): a 2 × 2 factorial randomised controlled trial. Health Technology Assessment 19(102): 1-104, 2016